Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells
Open accessThe DOI matches its Crossref record.
Abstract
Gene delivery has shown potential in a wide variety of applications, including basic research, therapies for genetic and acquired diseases, and vaccination. Most available nonviral systems have serious drawbacks such as the inability to control and scale the production process in a reproducible manner. Here, we demonstrate a biotechnologically feasible approach for gene delivery, using synthetic cationic amphipathic peptides containing a variable number of histidine residues. Gene transfer to different cell lines in vitro was achieved with an efficiency comparable to commercially available reagents. We provide evidence that the transfection efficiency depends on the number and positioning of histidine residues in the peptide as well as on the pH at which the in-plane to transmembrane transition takes place. Endosomal acidification is also required. Interestingly, even when complexed to DNA these peptides maintain a high level of antibacterial activity, opening the possibility of treating the genetic defect and the bacterial infections associated with cystic fibrosis with a single compound. Thus, this family of peptides represents a new class of agents that may have broad utility for gene transfer and gene therapy applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588
Thomas, M., & Klibanov, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1233634100 · Cited by 549
Midoux, P., Pichon, C., Yaouanc, J., & Jaffrès, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00288.x · Cited by 548
Surface-Engineered Dendrimers in Gene Delivery
Yang, J., Zhang, Q., Chang, H., & Cheng, Y. (2015) · Chemical Reviews · doi:10.1021/cr500542t · Cited by 429
Intracellular trafficking of nonviral vectors
Medina-Kauwe, L. K., Xie, J., & Hamm-Alvarez, S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302592 · Cited by 346
Antimicrobial peptides: New candidates in the fight against bacterial infections
Toke, O. (2005) · Peptide Science · doi:10.1002/bip.20286 · Cited by 322
Martin, M. E., & Rice, K. G. (2007) · The AAPS Journal · doi:10.1208/aapsj0901003 · Cited by 319
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Brogden, N. K., & Brogden, K. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.004 · Cited by 300
Lo, S. L., & Wang, S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.031 · Cited by 290
Mechanistic Landscape of Membrane-Permeabilizing Peptides
Guha, S., Ghimire, J., Wu, E., & Wimley, W. C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00520 · Cited by 280
Wang, T., Upponi, J. R., & Torchilin, V. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.013 · Cited by 268
Multifunctional antimicrobial materials: From rational design to biomedical applications
Duan, S., Wu, R., Xiong, Y.-H., Ren, H.-M., Lei, C., Zhao, Y.-Q., Zhang, X.-Y., & Xu, F.-J. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2021.100887 · Cited by 257
Moore, N. M., Sheppard, C. L., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1234 · Cited by 63
Receptor-mediated gene transfer vectors: progress towards genetic pharmaceuticals
Molas, M., Gomez-Valades, A., Vidal-Alabro, A., Miguel-Turu, M., Bermudez, J., Bartrons, R., & Perales, J. (2003) · Current Gene Therapy · doi:10.2174/1566523034578195 · Cited by 33
Metadata
- Authors
- Kichler, A., Leborgne, C., März, J., Danos, O., & Bechinger, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-01-31
- Volume
- 100
- Issue
- 4
- Pages
- 1564-1568
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2044194952
- Cited by
- 226
- References
- 0
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.